Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-01

Clinical Trial Update: Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients With Pulmonary Hypertension Group 2 (PreVail-PH2 OUS Study) [NA]

View source ↗

Summary

Clinical trial update for the Gradient Denervation Technologies 'Pulmonary Artery DenerVation' study (PreVail-PH2 OUS) in heart failure patients with pulmonary …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Gradient Denervation Technologies | Conditions: Pulmonary Hypertension | NA | Status: RECRUITING